Hotel occupancy down in October

October overnight stays reached 1.7 million, of which 1.1 million were Israelis and 531,000 were tourists.

November 24, 2005 06:42
1 minute read.


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Israel's hotels saw a slight decline in occupancy in October despite a 32 percent rise in the number of overnight lodgings, the Central Bureau of Statistics and the Israel Hotels Association said Wednesday. CBS and IHA said that occupancy fell to 55% in October, from 57% last year, without giving reason for the drop. October overnight stays reached 1.7 million, of which 1.1 million were Israelis and 531,000 were tourists. Over the more comparable September/October period, in which the Jewish holiday season fell in both years, lodgings rose 16% this year over last to 3.3 million. The report said that 40% of tourist's bookings were in Jerusalem hotels in October, while Eilat proved to be the most popular destination for Israelis with about 50% of their bookings.

More about:Jerusalem, Eilat, CBS

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection


Cookie Settings